Novavax Inc. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) sank 0.51% to $11.80 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.64% to 11,001.10 and the Dow Jones Industrial Average rising 0.64% to 34,189.97. This was the stock's second consecutive day of losses. Novavax Inc. closed $117.05 below its 52-week high ($128.85), which the company achieved on January 13th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.50% to $174.00, Pfizer Inc. (PFE) rose 0.55% to $47.71, and Merck & Co. Inc. (MRK) rose 0.63% to $111.77. Trading volume (6.2 M) remained 539,211 below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 12, 2023.
(END) Dow Jones Newswires
January 12, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.